1Mizshima Y, Yanagawa A, Hoshi K. Prostaglandin E1 is more effective, when incorporated in lipid microspheres, for treatment of peripheral vascular diseades in man. J Pharm Pharmacol, 1983, 35:666-667.
2Awad I, Little JR, Lucas F, et al. Treatment of acute focal cerebral ischemia with prostacyclin. Stroke, 1983, 14:203-209.
3Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 1980, 288:373-376.
5Sawada Y, Sugawara M, Hatayama I, et al. A study of topical and systemic prostaglandin E1 and survival of experimental skin flaps. Br J Plast Surg, 1993, 46:670-672.
6Kuwahara H, Sugihara T, Ohura T, et al. Effects of lipoprostaglandin E1 on random pattern flaps in rabbits. Scand J Plast Reconstr Hand Surg, 1996, 30:23-28.
7Menger MD, Vollmar B. In vivo analysis of microvascular reperfusion iniury in striated muscle and skin. Microsurgery, 1994, 15(6): 383-389.
8Stiegelmar R, McKee MD, Waddell JP, et al. Outcome of foot injures in multiply injured patients. Orthop Clin North Am, 2001, 32(1): 193-204.
9M. Angstwurm,J. Hoffmann,H. Ostermann,L. Frey,M. Spannagl.Schwere Sepsis und disseminierte intravasale Gerinnung[J]. Der Anaesthesist . 2009 (2)
10Johnston CC,Dowers SL,Urbanski RJ.Examination of the filtera-bility of oxygenated erythrocytes (containing normal,trait or sicklecell disease type hemoglobins)in the presence of L-epinephrine,D,L-isoproterenol or prostaglandins (PG)A1,A2,E1,E2,F1alphaor F2alpha. Prostaglandins . 1977
